Immunological veterinary medicinal products, including vaccines, are authorised for cattle.
Search results 1 to 25 from a total of 64
| Name | Description | Marketing Authorisation Holder | License Number | License Date | Animal | Further Information |
|---|---|---|---|---|---|---|
|
Rispoval IBR-Marker vivum |
BHV1-Infektion |
Zoetis Deutschland GmbH |
496a/93 | 28.10.1994 | Rind | |
|
Hiprabovis IBR Marker Live |
BHV1-Infektion |
Laboratorios Hipra S.A., Spanien |
EU/2/10/114/001-002 | 27.01.2011 | Rind | |
|
Rispoval IBR-Marker inactivatum |
BHV1-Infektion |
Zoetis Deutschland GmbH |
497a/93 | 28.10.1994 | Rind | |
|
Bovilis IBR Marker live |
BHV1-Infektion |
Intervet Deutschland GmbH |
PEI.V.11616.01.1 | 02.02.2012 | Rind | |
|
Bovilis IBR Marker inac |
BHV1-Infektion |
Intervet Deutschland GmbH |
PEI.V.03246.01.1 | 23.09.2005 | Rind | |
|
Bluevac-4 |
Blauzungenkrankheit, Serotyp 4 |
CZ Veterinaria S.A., Spanien |
PEI.V.11839.01.1 | 25.05.2016 | Schaf, Rind | |
|
Bovilis Blue-8 |
Blauzungenkrankheit, Serotyp 8 |
Intervet International B.V., Niederlande |
EU/2/17/218/001-003 | 21.11.2017 | Rind, Schaf | |
Bluevac BTV |
Blauzungenkrankheit, Serotyp 8, 4 oder 1 |
CZ Veterinaria S.A., Spanien |
EU/2/11/122/001-003 | 14.04.2011 | Schaf, Rind | |
|
Zulvac 1+8 Bovis |
Blauzungenkrankheit, Serotypen 1 und 8 |
Zoetis Belgium S.A., Belgien |
EU/2/12/139/001-003 | 08.03.2012 | Rind | |
|
BTVPUR |
Blauzungenkrankheit, Serotypen 1, 2, 4 oder 8 |
Boehringer Ingelheim Vetmedica GmbH |
EU/2/10/113/001-050 | 17.12.2010 | Rind, Schaf | |
|
Zulvac BTV |
Blauzungenkrankheit, Serotypen 1, 4 oder 8 |
Zoetis Belgium S.A., Belgien |
EU/2/17/207/001-009 | 25.04.2017 | Rind, Schaf | |
|
SYVAZUL BTV |
Blauzungenkrankheit, Serotypen 1, 4 oder 8 |
Laboratorios Syva, S.A.U., Spanien |
EU/2/18/231/001-012 | 09.01.2019 | Schaf, Rind | |
|
Rispoval RS |
BRSV-Infektion |
Zoetis Deutschland GmbH |
116a/89 | 28.10.2005 | Rind | |
NASYM |
BRSV-Infektion |
Laboratorios Hipra S.A., Spanien |
EU/2/19/241 | 29.07.2019 | Rind | |
|
Rispoval RS+PI3 IntraNasal |
BRSV-Infektion, |
Zoetis Deutschland GmbH |
PEI.V.03416.01.1 | 15.08.2006 | Rind | |
|
Rispoval 3-BRSV-PI3-BVD |
BRSV-Infektion, |
Zoetis Deutschland GmbH |
PEI.V.03128.01.1 | 21.04.2005 | Rind | |
Rispoval 2 / BRSV + Pi3 |
BRSV-Infektion, Bovine Parainfluenza |
Zoetis Deutschland GmbH |
PEI.V.12018.01.1 | 18.11.2020 | Rind | |
|
Bovilis IntraNasal RSP Live |
BRSV-Infektion, Bovine Parainfluenza |
Intervet Deutschland GmbH |
PEI.V.11976.01.1 | 18.05.2019 | Rind | |
|
BOVALTO Respi Intranasal |
BRSV-Infektion, Parainfluenza-3 |
Boehringer Ingelheim Vetmedica GmbH |
PEI.V.11947.01.1 | 19.03.2018 | Rind | |
|
Mucosiffa |
BVD/MD |
Ceva Tiergesundheit GmbH |
PEI.V.03518.01.1 | 06.03.2008 | Rind | |
|
Bovela |
BVD/MD |
Boehringer Ingelheim Vetmedica GmbH |
EU/2/14/176/001-016 | 22.12.2014 | Rind | |
|
Bovilis BVD-MD |
BVD/MD |
Intervet Deutschland GmbH |
180a/96 | 18.05.1998 | Rind | |
Bovilis Nasalgen-C |
Coronavirus-Infektion |
Intervet International B.V., Netherlands |
EU/2/23/294 | 31.03.2023 | Rind | |
|
Covexin Zehn |
Enterotoxämie, |
Zoetis Deutschland GmbH |
PEI.V.03186.01.1 | 24.09.2004 | Rind, Schaf | |
|
Covexin 8 |
Enterotoxämie, |
Zoetis Deutschland GmbH |
A263/79 | 24.10.2005 | Rind, Schaf, Schwein |
The list of medicines contains the products that have a valid marketing authorization. It contains no information as to whether the preparations are available on the market.
The information contained in the Federal Gazette, which is the official publication organ of the Paul-Ehrlich-Institut, is legally binding.
As of: PEI announcement No. 515 in BAnz AT 09.04.2024 B3.
Where the European Medicines Agency (EMA) offers further information, you will find a link to the EPAR (European public assessment report) in the table.
If user and technical information or public assessment reports are available in PharmNet.Bund, the Federal and State Pharmaceutical Information Portal, these are directly linked to PharmNet.Bund in the table.
Updated: 09.04.2024
